Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Hiddensecretson Mar 05, 2021 12:21am
134 Views
Post# 32725411

Detroit DECLINES Johnson and Johnson vaccine

Detroit DECLINES Johnson and Johnson vaccine

Detroit declined Johnson & Johnson COVID-19 vaccine, but may eventually administer it

 

Detroit — Detroit Mayor Mike Duggan said Thursday his decision to turn down 6,200 doses of the Johnson & Johnson COVID-19 vaccine earlier this week didn't result in any Detroiters losing out on vaccination opportunities.
 

The city declined the 6,200 doses because officials wanted to focus instead on vaccines that are "the best" in the market, Duggan said. 

"Johnson & Johnson is a very good vaccine, but Moderna and Pfizer are the best.

https://www.detroitnews.com/story/news/local/detroit-city/2021/03/04/vaccine-detroit-johnson-johnson-covid-19-vaccinations-mayor-mike-duggan/6919685002/

MPO


<< Previous
Bullboard Posts
Next >>